Cingulate Inc (CING) Stock Price, Quote & News

Company Profile

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In...

Industry: Biotechnology

Sector: Healthcare

Phone: 913 942 2300

Website: www.cingulate.com

Address:

1901 West 47th Place, Kansas City, United States

CARTE_BLANCHE_DEVEREAUX Jul. 3 at 6:55 PM

$SLS $ATHE $CING $PYPD It's been 1 year (and 2 days) since I posted this. How did you guys do this year? What do you guys have planned for the next year? Are you paying attention (and contributing) to the Discord?

2 · Reply

jacob_Berkstein_ Jul. 3 at 2:35 PM

$CING sls pumper clan is doing short attack against cing, no problem

0 · Reply

VelorexCapital Jul. 2 at 8:01 PM

$CING strangest trading session I have ever seen. No reason for the pullback today. But we live and we move on. EXTREMELY BULLISH

3 · Reply

ZacksResearch Jul. 2 at 6:37 PM

$CING gains 24.1% YTD: Will the Momentum Continue? The stock continues to gain momentum despite CRL. $CING enters Q2 with a much stronger balance sheet. 💰 Cash and cash equivalents jumped to $25.9M, up $14.9M from year-end 2025. 📈 Working capital surged to $17.0M from $1.7M 🤖 The company is also deploying AI-augmented tools to support commercialization efforts See what Wall Street expects next 👉 https://www.zacks.com/stock/research/CING/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38623&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38623

0 · Reply

activehybrid Jul. 2 at 4:01 PM

$CING September is the fda meeting because of vacations holidays Plus 2 month to prepare fda approval documents December is the nda application Q2 2026 presentation shows they are expecting to sell this drug by q2 2027 ! Some genius people ask me how do I know ! Read the presentation, go check Since company burns 7.5 million cash per quarter , 30 million cash is not going to be enough $4 is coming

2 · Reply

VCV86 Jul. 2 at 2:59 PM

$UNCY $CING $ACHV if you like post-CMC CRL setups, $GRCE looks like a great opportunity here. The stock has been hammered, and FDA alignment after the Type A meeting could come anytime.

3 · Reply

DonkeyClanbrands Jul. 2 at 2:54 PM

$CING is there news??

1 · Reply

Laacy Jul. 2 at 2:33 PM

$CING why yyyy

1 · Reply

BimmernutZ Jul. 2 at 2:18 PM

$CING Whole market is rocketing thru the roof and this is dropping, wtf

0 · Reply

Idfkytm Jul. 2 at 2:10 PM

$SLS $OCGN $CING $CTGO $TNYA My account looks insane today

1 · Reply

Market Cap	72.46M
Revenue (ttm)	0.00
Net Income (ttm)	-22.45M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	378,200
Avg Vol	594,114
Day's Range	N/A - N/A
Shares Out	13.47M
Stochastic %K	52%
Beta	-0.91
Analysts	Strong Sell
Price Target	$23.00